US-based digital health solutions provider Epicore Biosystems has secured $26m in a Series B financing round, led by the Steele Foundation for Hope (SFFH), a non-profit organisation.
Epicore was established in October 2023 as a spin-out of Northwestern University’s Querrey Simpson Institute for Bioelectronics and the John Rogers Laboratory.
The digital health company has developed advanced sweat-sensing wearables that provide real-time personalised health insights.
Its portfolio of sweat-sensing solutions includes the Gx Sweat Patch, marketed in partnership with PepsiCo and Gatorade, the Discovery Patch Sweat Collection System (FDA Class I device) and the Connected Hydration wearable and cloud platform.
Epicore will use the funding to drive global adoption of its personalised hydration and cloud analytics platform and expand into new biomarker targets.
The company will focus on kidney health, women’s health, malnutrition and toxin exposures.
Epicore Biosystems CEO and co-founder Roozbeh Ghaffari said: “Epicore has developed a new class of biochemical sensing wearables that enable the sports, fitness and connected worker sectors to unlock key health and wellness insights.
“Our technology delivers data-driven recommendations to the wearer to help manage these types of challenges.
“The Series B investment will help expand our global reach and accelerate the validation of new biomarkers needed to shape the future of personalised hydration and wellness strategies for all.”
According to Epicore, exposure to excessive heat may lead to significant global challenges, particularly for people at elevated risk of heat injury.
The company said that its sweat-sensing solutions will address the challenge of exposure to heat and toxins through real-time insights into hydration, stress, nutrition and wellness.
Epicore said its technology will tap the underlying biochemistry and metabolic health by non-invasively measuring sweat composition and fluid losses.
The technology works together with conventional digital biomarkers to alert when the patient is at risk of heat injury, dehydration or malnutrition.
Steele Foundation for Hope CEO Joe Exner said: “Epicore’s commitment to improving personalised health for those in critical need aligned strongly with our mission to improve the quality of life for people in need worldwide.
“We are proud to back Epicore’s pioneering work in sweat-monitoring technology, an innovation with significant potential to address the critical health challenges frontline populations face due to climate change.”
